182 related articles for article (PubMed ID: 38654320)
1. CircCDYL2 bolsters radiotherapy resistance in nasopharyngeal carcinoma by promoting RAD51 translation initiation for enhanced homologous recombination repair.
Qu H; Wang Y; Yan Q; Fan C; Zhang X; Wang D; Guo C; Chen P; Shi L; Liao Q; Zhou M; Wang F; Zeng Z; Xiang B; Xiong W
J Exp Clin Cancer Res; 2024 Apr; 43(1):122. PubMed ID: 38654320
[TBL] [Abstract][Full Text] [Related]
2. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways.
Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX
Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071
[TBL] [Abstract][Full Text] [Related]
4. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autophagy enhances the radiosensitivity of nasopharyngeal carcinoma by reducing Rad51 expression.
Mo N; Lu YK; Xie WM; Liu Y; Zhou WX; Wang HX; Nong L; Jia YX; Tan AH; Chen Y; Li SS; Luo BH
Oncol Rep; 2014 Nov; 32(5):1905-12. PubMed ID: 25175062
[TBL] [Abstract][Full Text] [Related]
6. High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma.
Feng P; Wang Y; Liu N; Chen Y; Hu Y; Huang Z; Liu Y; Zheng S; Jiang T; Xiao X; Dai W; Huang P; Xia Y
Cell Death Differ; 2024 May; 31(5):683-696. PubMed ID: 38589496
[TBL] [Abstract][Full Text] [Related]
7. The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma.
Wang Z; Zuo W; Zeng Q; Li Y; Lu T; Bu Y; Hu G
Int J Biol Sci; 2020; 16(3):408-419. PubMed ID: 32015678
[TBL] [Abstract][Full Text] [Related]
8. Elp1 facilitates RAD51-mediated homologous recombination repair via translational regulation.
Chen WT; Tseng HY; Jiang CL; Lee CY; Chi P; Chen LY; Lo KY; Wang IC; Lin FJ
J Biomed Sci; 2021 Nov; 28(1):81. PubMed ID: 34819065
[TBL] [Abstract][Full Text] [Related]
9. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
Xie Z; Li W; Ai J; Xie J; Zhang X
J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
[TBL] [Abstract][Full Text] [Related]
10. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
Zhang P; Shao Y; Quan F; Liu L; Yang J
Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
[TBL] [Abstract][Full Text] [Related]
11. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.
Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT
Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142
[No Abstract] [Full Text] [Related]
12. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
13. circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer.
Ling Y; Liang G; Lin Q; Fang X; Luo Q; Cen Y; Mehrpour M; Hamai A; Liu Z; Shi Y; Li J; Lin W; Jia S; Yang W; Liu Q; Song E; Li J; Gong C
Mol Cancer; 2022 Jan; 21(1):8. PubMed ID: 34980129
[TBL] [Abstract][Full Text] [Related]
14. Silencing NFBD1/MDC1 enhances the radiosensitivity of human nasopharyngeal cancer CNE1 cells and results in tumor growth inhibition.
Wang Z; Zeng Q; Chen T; Liao K; Bu Y; Hong S; Hu G
Cell Death Dis; 2015 Aug; 6(8):e1849. PubMed ID: 26247734
[TBL] [Abstract][Full Text] [Related]
15. AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma.
Liu X; Hu Z; Qu J; Li J; Gong K; Wang L; Jiang J; Li X; He R; Duan L; Luo W; Xia C; Luo D
Int J Biol Sci; 2021; 17(3):756-767. PubMed ID: 33767586
[TBL] [Abstract][Full Text] [Related]
16. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
[TBL] [Abstract][Full Text] [Related]
17. FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway.
Chen E; Huang J; Chen M; Wu J; Ouyang P; Wang X; Shi D; Liu Z; Zhu W; Sun H; Yang S; Zhang B; Deng W; Qiu H; Xie F
J Transl Med; 2023 Feb; 21(1):134. PubMed ID: 36814284
[TBL] [Abstract][Full Text] [Related]
18. The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis.
Li Y; Zhou Y; Zhao C; Liu L; He Q; Shang K; Xu X; Luo X; Zhou D; Jin F
Oral Oncol; 2024 May; 152():106798. PubMed ID: 38615583
[TBL] [Abstract][Full Text] [Related]
19. O6-methylguanine-DNA methyltransferase modulates cisplatin-induced DNA double-strand breaks by targeting the homologous recombination pathway in nasopharyngeal carcinoma.
Chen SH; Huang WT; Kao WC; Hsiao SY; Pan HY; Fang CW; Shiue YL; Chou CL; Li CF
J Biomed Sci; 2021 Jan; 28(1):2. PubMed ID: 33397362
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2.
Mo Y; Wang Y; Zhang S; Xiong F; Yan Q; Jiang X; Deng X; Wang Y; Fan C; Tang L; Zhang S; Gong Z; Wang F; Liao Q; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W
Mol Cancer; 2021 Aug; 20(1):112. PubMed ID: 34465340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
